# FDA Inspection 1058601 - Department of Defense - Air Force - June 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-air-force/a1d46a70-b9c2-42f3-994e-218e45bb3e26
Source feed: FDA_Inspections

> FDA Inspection 1058601 for Department of Defense - Air Force on June 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058601
- Company Name: Department of Defense - Air Force
- Inspection Date: 2018-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1236255 - 2023-10-25](https://www.keypedia.com/records/fda_inspections/department-of-defense-air-force/2be47fca-da63-4375-93ab-a6e2ac95883e)
- [FDA Inspection 950625 - 2015-12-04](https://www.keypedia.com/records/fda_inspections/department-of-defense-air-force/337b2501-3f11-4ae0-9d74-1ab8cab87f34)
- [FDA Inspection 846081 - 2013-08-23](https://www.keypedia.com/records/fda_inspections/department-of-defense-air-force/ed52ad80-5ef0-49a0-a16a-1690e5e6f887)
- [FDA Inspection 700389 - 2010-11-23](https://www.keypedia.com/records/fda_inspections/department-of-defense-air-force/b92a8504-4828-4835-9c55-c61aeceaab49)

Company: https://www.keypedia.com/companies/department-of-defense-air-force/06dbbcfe-9082-4749-a70f-da2393e2435e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d